Overview
Axel Rufer practices practicing medicine in Luzern, Switzerland.
Mr. Rufer is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP).
He is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Axel Rufer
Is Axel Rufer a top-rated expert for Mast Cell Activation Syndrome (MCAS)?
MediFind is an objective health platform that identifies experts based on real-world data. Axel Rufer is classified as an Advanced expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Axel Rufer participate in research or clinical trials?
Yes. Axel Rufer has published 32 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Axel Rufer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mast Cell Activation Syndrome (MCAS)
- Systemic MastocytosisMr. Rufer isAdvanced. Learn about Systemic Mastocytosis.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Rufer isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaMr. Rufer isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnaphylaxisMr. Rufer isExperienced. Learn about Anaphylaxis.
- Blood ClotsMr. Rufer isExperienced. Learn about Blood Clots.
- Chronic Myelomonocytic Leukemia (CMML)
- HemochromatosisMr. Rufer isExperienced. Learn about Hemochromatosis.
- Immune Thrombocytopenic Purpura (ITP)Mr. Rufer isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- LeukemiaMr. Rufer isExperienced. Learn about Leukemia.
- Multiple MyelomaMr. Rufer isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Mr. Rufer isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Myeloproliferative Neoplasms (MPN)Mr. Rufer isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMr. Rufer isExperienced. Learn about Polycythemia Vera.
- Primary AmyloidosisMr. Rufer isExperienced. Learn about Primary Amyloidosis.
- PurpuraMr. Rufer isExperienced. Learn about Purpura.
- Relapsed Refractory Multiple Myeloma (RRMM)
- SarcoidosisMr. Rufer isExperienced. Learn about Sarcoidosis.
- SplenomegalyMr. Rufer isExperienced. Learn about Splenomegaly.
- ThalassemiaMr. Rufer isExperienced. Learn about Thalassemia.
- ThrombocytopeniaMr. Rufer isExperienced. Learn about Thrombocytopenia.